RxDoctor Payments Data

Regina Raab

Neurology · Lexington, KYNPI 1851443378

Payments from drug & device makers

$1,534in general payments, 2019–2025

Across 107 payments — averaging $14.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$353
  • Biohaven Pharmaceutical Holding Company Ltd.$203
  • Biohaven Pharmaceuticals, Inc.$154
  • Harmony Biosciences LLC$98
  • Amgen$88
  • SK Life Science, Inc.$87
  • plus $551 from 11 others

What the payments were for

  • Food & beverage$1,47896%
  • Education$564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,534 in reported general payments places this provider in the 40th percentile of 210 neurology providers in Kentucky.

See all neurology providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rivastigmine14$3,305
Memantine Hcl65$1,454
Carbidopa-LevodopaCarbidopa/Levodopa31$706
Sumatriptan Succinate11$706
Donepezil Hcl54$434
Levetiracetam11$345
Pramipexole DihydrochloridePramipexole Di-Hcl16$212
Trazodone Hcl15$194
Duloxetine Hcl12$187
Gabapentin17$182
AmantadineAmantadine Hcl11$160
Topiramate12$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Upsher-smith Laboratories LLCTopiramate$52$5912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 210 neurology providers in Kentucky.

Other neurology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →